Robert A. Kagan discusses how litigation shapes regulation, policymaking, and accountability in the United States.

This year has brought a range of challenges for biopharma companies and their leaders, including on-and-off tariff threats and President Donald Trump's arm-twisting around overseas drug spending. Now, ...

Regulatory changes are the biggest risk to shipping in 2026, according to a survey by insurer Allianz, overtaking natural ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

August 19, 2022 - Companies today face increased risks from numerous regulatory bodies at the municipal, state, and federal levels. As we discussed in our previous article, opens new tab, "Preparing ...

Streamline your regulatory reporting process with an efficient, automated, end-to-end solution built for the global market. The global financial market moves in real time. Brokers and trading ...

Dr Venu Murthy is a Technocrat with 20+ years of experience in driving digital transformations of fast growing companies and an innovator. As a technologist, I was blind to a crucial aspect of any ...

Regulatory Affairs Specialists work to ensure that biotechnology or biopharmaceutical products meet all the quality attributes — safety, efficacy, potency and purity — required by customers and ...

In Q3 2025, Riot Platforms Inc. (NASDAQ:RIOT) generated a total revenue of $180.2 million, which more than doubled the $84.8 ...

Moody’s cyber outlook report — part of a series of 2026 forecasts that business leaders are tracking closely — predicts that ...

Regulatory affairs professionals are meticulous, strive for perfection, and have a strong sense of ethics and interest in regulations. Regulatory affairs professionals ensure that new drugs and ...